NCT04128514 is a clinical trial of Panoptix Toric in Cataract, sponsored by Eye Center of North Florida.

Who is sponsoring NCT04128514?

NCT04128514 is sponsored by Eye Center of North Florida.

What drugs are being tested in NCT04128514?

Interventions in NCT04128514: Panoptix Toric.

Is NCT04128514 still recruiting?

NCT04128514 is currently terminated. Last updated 1 April 2022.

Last reviewed 2022-04-01 · How we verify

NCT04128514

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Spectacle Independence and Overall Satisfaction With AcrySof® Panoptix® Toric Intraocular Lens

Terminated Last updated 1 April 2022

What this trial tests

trial testing Panoptix Toric in Cataract in 15 participants. Terminated before completion.

Timeline

11 October 2019

Primary endpoint
10 March 2022

10 March 2022

Quick facts

Lead sponsor	Eye Center of North Florida
Status	Terminated
Study type	OBSERVATIONAL
Enrollment	15
Start date	11 October 2019
Primary completion	10 March 2022
Estimated completion	10 March 2022
Sites	1 location across United States

Drugs / interventions tested

Panoptix Toric

Conditions studied

Cataract — all drugs for Cataract →

Sponsor

Eye Center of North Florida — full company profile →

Who can join

40 and older, any sex, with Cataract. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The study was designed to assess the spectacle independence and satisfaction of patients receiving the AcrySof® Panoptix® Toric intraocular lens (IOL) after uneventful cataract surgery.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other recruiting trials for Cataract

Currently open trials in the same condition.

NCT07301385 — Evaluation of Head-Mounted Spatial Computing and Three-Dimensional (3D) Visualization in Ocular Microsurgery: A Safety a · NA · recruiting
NCT07462000 — Aqueous Humor and Ocular Tissue Analysis in Glaucoma and Cataract · NA · recruiting
NCT06891092 — Vivinex Impress XY1-EM vs RayOne EMV · NA · recruiting
NCT07218796 — Evaluation of the Safety and Efficacy of the Bimatoprost Implant System Used in Combination With the SpyGlass IOL Compar · Phase 3 · recruiting
NCT07218783 — Evaluation of the Safety and Efficacy of the Bimatoprost Implant System Used in Combination With the SpyGlass IOL Compar · Phase 3 · recruiting

Other Eye Center of North Florida trials

Trials by the same sponsor.

NCT03326869 — A Study Raindrop Near Vision Inlay in Presbyopes Implanted in Corneal Pockets · NA · terminated

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT04128514 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Eye Center of North Florida
Last refreshed: 1 April 2022

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04128514.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing